Found 74 All Conditions trials

Below is a list of actively recruiting clinical trials based on your search for "All Conditions"

2 years - 5 years
All genders
Phase 3
Interventional
This study investigates the effects of an investigational medication on children aged 2 to less than 6 years with uncontrolled asthma or severe asthmatic wheeze. The purpose is to understand how this medication can affect these young patients who have difficulty managing their asthma symptoms.The study focuses on evaluating the …
12 years or above
All genders
Phase 3
Interventional
This study investigates the effectiveness and safety of a subcutaneous treatment for people aged 12 and older with moderate-to-severe atopic dermatitis. Participants in this study have not responded well to previous treatments, such as biologic therapies or oral JAK inhibitors.The study focuses on understanding how well the treatment works and …
18 years - 45 years
All genders
Phase 1/2
Interventional
This study investigates the safety, efficacy, and immune response of an investigational mRNA vaccine for adults aged 18 to 45 with moderate to severe acne. This study aims to explore new possibilities for treating this condition with a vaccine approach.The study focuses on evaluating how well the investigational mRNA vaccine …
16 years - 75 years
All genders
Phase 2
Interventional
This study investigates the effects of investigational medications on individuals with primary focal segmental glomerulosclerosis (FSGS) or primary minimal change disease (MCD). These are kidney conditions that can lead to nephrotic syndrome, characterized by high levels of protein in the urine.The study focuses on evaluating how these investigational medications impact …
18 years or above
All genders
Phase 2
Interventional
This study investigates the long-term safety and effectiveness of an investigational medication in adults with asthma.The focus of this study is to observe how well the investigational medication works over an extended period and to monitor any side effects that may occur. The study aims to provide more information about …
18 years or above
All genders
Phase 1
Interventional
This study investigates the safety and effectiveness of an investigational medication for adults with relapsed or refractory myeloma. The research aims to understand how well the medication works and how safe it is for people who have tried other treatments without success.The study focuses on evaluating the investigational medication's effects …
18 years or above
Accepts healthy volunteer
Male
Phase 3
This study investigates the ability of participants to appropriately select and use an investigational medication for erectile dysfunction using specific labeling and a health survey assessment (HSA). The study will enroll men interested in an over-the-counter treatment for this condition.Participants will enter the study through an open-label process, meaning both …
10 years - 55 years
All genders
Phase 1/2
Interventional
This study investigates the safety and effectiveness of a gene therapy for people with non-congenital myotonic dystrophy type 1 (DM1).The focus of this study is to understand how the gene therapy can lower certain protein levels in the body and improve muscle function in participants with DM1.Who can participate: Participants …
10 years - 65 years
All genders
Phase 3
Interventional
This study investigates the efficacy and safety of an investigational medication in individuals with sickle-cell disease. The study focuses on evaluating how well the investigational medication works and how safe it is for people with sickle-cell disease. It aims to gather information that could help understand the medication's effects better.Who …
12 years or above
All genders
Phase 4
Interventional
This study investigates the effects of an investigational medication given once a week to people with Hemophilia A who have joint swelling known as synovial hypertrophy. Participants in this study will receive the investigational medication once a week for about 12 months. During the study, doctors will monitor the participants' …